Effectiveness of carbazochrome sodium sulfonate in reducing hemorrhage during TURP for BPH: A systematic review
Abstract
Evidence from the past five years has highlighted increasing interest in pharmacological adjuncts at improving transurethral resection of the the prostate (TURP). Both randomized controlled trials (RCTs) and observational research have investigated the role of carbazochrome sodium sulfonate (CSS), with varying results. This systematic review aimed to evaluate the effectiveness of CSS in transurethral resection of the prostate (TURP) for benign prostatic hyperplasia (BPH). The review was conducted in accordance with the Prefrred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. A comprehensive search of Embase, PubMed/MEDLINE, Scopus, Web of Science, and the Cochrane Library was performed. Eligible studies included cohort studies, case-control methodologies, and RCT investigations related to CSS in TURP procedures and reporting outcomes such as blood loss and complications. Five RCTs comprising a total of 550 participants met the inclusion criteria. The findings indicated that CSS was associated with a significant reduction in intraoperative bleeding compared with tranexamic acid (TXA). Across all studies, CSS exhibited a favorable safety profile, with no severe adverse effects reported. CSS appears to be a promising advancement in managing perioperative bleeding during TURP procedures for BPH. Its hemostatic efficacy and safety profile suggest potential benefits for surgical outcomes and patient recovery. Nevertheless, further high-quality,…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 550 participants or records.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.